{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/flusync-proactively-optimizing-clinical-trial-operations-and-aligning-resources-integrated#webpage",
"url": "https://www.fortrea.com/insights/flusync-proactively-optimizing-clinical-trial-operations-and-aligning-resources-integrated",
"name": "FluSync: Proactively optimizing clinical trial operations and aligning resources with integrated disease prevalence insights",
"description": "Explore this Fortrea white paper on integrated disease prevalence insights and discover how advanced disease surveillance analytics can help optimize clinical trial operations in infectious disease research. The white paper examines the limitations of traditional influenza surveillance methods and explores how integrated disease prevalence insights, site-level disease activity monitoring, automated site flagging, and data-driven operational strategies can support more informed decision-making across clinical trial programs. Learn how disease prevalence analytics, influenza incidence tracking, resource alignment strategies, operational planning, site selection optimization, and real-time monitoring approaches are helping sponsors and clinical research teams improve trial efficiency, proactively allocate resources, respond to changing disease patterns, and strengthen execution across infectious disease clinical trials. "
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "FluSync: Proactively optimizing clinical trial operations and aligning resources with integrated disease prevalence insights",
"item": "https://www.fortrea.com/insights/flusync-proactively-optimizing-clinical-trial-operations-and-aligning-resources-integrated"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/flusync-proactively-optimizing-clinical-trial-operations-and-aligning-resources-integrated#whitepaper",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/flusync-proactively-optimizing-clinical-trial-operations-and-aligning-resources-integrated#webpage"
},
"headline": "Integrated Disease Prevalence Insights for Clinical Trial Operations Optimization | Fortrea White Paper",
"description": "Explore this Fortrea white paper on integrated disease prevalence insights and discover how advanced disease surveillance analytics can help optimize clinical trial operations in infectious disease research. The white paper examines the limitations of traditional influenza surveillance methods and explores how integrated disease prevalence insights, site-level disease activity monitoring, automated site flagging, and data-driven operational strategies can support more informed decision-making across clinical trial programs. Learn how disease prevalence analytics, influenza incidence tracking, resource alignment strategies, operational planning, site selection optimization, and real-time monitoring approaches are helping sponsors and clinical research teams improve trial efficiency, proactively allocate resources, respond to changing disease patterns, and strengthen execution across infectious disease clinical trials. ",
"genre": "White Paper",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2026-02-02",
"dateModified": "2026-02-02",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2026-02/flusync-clinical-trial-operations-disease-prevalence.pdf",
"encodingFormat": "application/pdf"
}
}
]
}